Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.42 - $9.18 $4,161 - $90,955
9,908 Added 1.63%
618,673 $278,000
Q1 2022

May 13, 2022

BUY
$1.6 - $3.35 $69,251 - $144,994
43,282 Added 7.65%
608,765 $1.07 Million
Q4 2021

Feb 11, 2022

BUY
$2.08 - $3.65 $361,067 - $633,603
173,590 Added 44.3%
565,483 $1.83 Million
Q3 2021

Nov 12, 2021

BUY
$1.35 - $4.01 $33,172 - $98,533
24,572 Added 6.69%
391,893 $1.57 Million
Q2 2021

Aug 13, 2021

BUY
$1.48 - $1.92 $26,462 - $34,329
17,880 Added 5.12%
367,321 $602,000
Q1 2021

May 12, 2021

BUY
$1.82 - $3.01 $91,709 - $151,673
50,390 Added 16.85%
349,441 $663,000
Q4 2020

Feb 12, 2021

BUY
$1.49 - $2.37 $193,534 - $307,836
129,889 Added 76.78%
299,051 $672,000
Q3 2020

Nov 13, 2020

BUY
$1.68 - $2.17 $38,050 - $49,148
22,649 Added 15.46%
169,162 $334,000
Q2 2020

Aug 13, 2020

SELL
$1.39 - $2.84 $3,982 - $8,136
-2,865 Reduced 1.92%
146,513 $306,000
Q1 2020

May 14, 2020

SELL
$1.06 - $2.94 $16,021 - $44,438
-15,115 Reduced 9.19%
149,378 $236,000
Q2 2019

Aug 14, 2019

BUY
$1.36 - $2.07 $78,172 - $118,983
57,480 Added 53.71%
164,493 $294,000
Q1 2019

May 14, 2019

BUY
$1.39 - $3.07 $95,765 - $211,510
68,896 Added 180.75%
107,013 $200,000
Q3 2018

Nov 13, 2018

BUY
$6.52 - $9.13 $23,472 - $32,868
3,600 Added 10.43%
38,117 $296,000
Q2 2018

Aug 14, 2018

BUY
$6.76 - $10.01 $233,334 - $345,515
34,517 New
34,517 $310,000

Others Institutions Holding LPTX

# of Institutions
1
Shares Held
265K
Call Options Held
0
Put Options Held
0

About LEAP THERAPEUTICS, INC.


  • Ticker LPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,021,400
  • Market Cap $254M
  • Description
  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...
More about LPTX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.